Keywords: ثابت; aFVII; activated FVII; AHA; acquired hemophilia A; anti-hFVIII; anti-human FVIII; aPCC; activated prothrombin complex concentrate; aPTT; activated partial thromboplastin time; AT; antithrombin; AUC; area under the curve; BPA; bypassing agent; BU; Bethesda
مقالات ISI ثابت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ثابت; BAC; blood alcohol concentration; BSA; bovine serum albumin; CD; cluster of differentiation; CFT; clot formation time; CT; clotting time; EDTA; ethylenediaminetetraacetic acid; FBS; fetal bovine serum; FVIII; coagulation factor VIII; FVIII:C; FVIII activi
Keywords: ثابت; Early intervention (education); Hemophilia; Illness behavior; Pain; Quality of life; Rehabilitation; FVIII; factor VIII; FIX; factor IX; IBQ; Illness Behavior Questionnaire; RMAV; repeated-measures analysis of variance; VAS; visual analog scale;
Keywords: ثابت; aPCC; activated prothrombin complex concentrate; aPL; antiphospholipid; FIX; factor IX; FMD; flow-mediated dilatation; FV; factor V; FVIII; factor VIII; HA; hemophilia A; HB; hemophilia B; HIV; human immunodeficiency virus; IMT; intima-media thickness; MT
Keywords: ثابت; Empirical; Recession; Fix; Float; Inflation; TargetE58; F33
Keywords: ثابت; BL/6; C57BL/6; EC; Endothelial cell; ePCR; Endothelial protein C receptor; FIX; Factor IX; FX; Factor X; HEQ; Hirudin Equivalent”; LPS; Lipopolysaccharide; PSGL-1; P-selectin glycoprotein ligand-1; TF; Tissue factor; TAT; Thrombin anti-thrombin; WT; Wil
A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots
Keywords: ثابت; FIX; Proteomics; Circular dichroism; Mass spectrometry;
Current view and outcome of ITI therapy - A change over time?
Keywords: ثابت; aPCC; activated prothrombin complex concentrate; d; day; BU; Bethesda units; ED; exposure days; EHTSB; European Haemophilia Therapy Strategy Board; FVIII; factor eight; FIX; factor nine; HA; haemophilia A; HB; haemophilia B; IS; immunosuppression; I-ITI;
Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigmâ¢4)
Keywords: ثابت; ABR; annualised bleeding rate; AEs; adverse events; CHO; Chinese hamster ovary; CI; confidence interval; EDs; exposure days; ELISA; enzyme-linked immunosorbent assay; FIX; factor IX; IQR; interquartile range; PEG; polyethylene glycol; PTPs; previously tre
Activation peptide of coagulation factor IX regulates endothelial permeability
Keywords: ثابت; FIX; coagulation factor IX; PECAM; platelet endothelial cell adhesion molecule; eNOS; endothelial nitric oxide synthase; cGMP; cyclic guanosine monophosphate; VEGF; vascular endothelial growth factor; cAMP; cyclic adenosine monophosphate; PVDF; polyvinyli
Improved sensitivity and specificity for resting state and task fMRI with multiband multi-echo EPI compared to multi-echo EPI at 7Â T
Keywords: ثابت; High field; Stroop; FIX; Physiological noise; Simultaneous multi-slice; ICA; Multi-echo; Precision;
Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor
Keywords: ثابت; AUC; area under the curve; Cl; clearance; DAB; 3,3â²-diaminobenzidine; dIF; double immunofluorescence; EGFR; epidermal growth factor receptor; GAG; glycosaminoglycans; GPI; glycosylphosphatidylinositol; FVIII; Factor VIII; FIX; Factor IX; FXa; Factor Xa;
Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats
Keywords: ثابت; FIX; factor IX; FIXa; activated FIX; rFIX; recombinant FIX; pdFIX; plasma-derived FIX; rIX-FP; recombinant fusion protein linking factor IX with albumin; QWBA; quantitative whole-body autoradiography; LSC; liquid scintillation counting; LMW; low-molecular
Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors
Keywords: ثابت; FVII; Factor VII; FVIII; Factor VIII; AAV; adeno-associated virus; F8KO; Factor VIII knock out; HCR; hepatic control region; HAAT; human alpha-1 antitrypsin; CMV; cytomegalovirus; SV40; simian virus 40; PCR; polymerase chain reaction; PT; prothrombin time
Is guarantee compensation enough? The important role of fix and employee effort in restoring justice
Keywords: ثابت; Service recovery; Unconditional service guarantee; Service failure severity; Fix; Perceived employee effort and hotels
Challenges in the laboratory analyses of bleeding disorders
Keywords: ثابت; aPTT; activated partial thromboplastin time; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; EQA; external quality assurance; FVIII; factor VIII; FIX; factor IX; FVIII:C; coagulation activity of FVIII; FIX:C; coagulation activ
Global haemostasis assays, from bench to bedside
Keywords: ثابت; α; angle that assesses rate of clot formation; α2M; α2-macroglobulin; AMC; 7-amino-4-methylcoumarine; AT; antithrombin; AUC; area under the curve; APC; activated protein C; aPTT; activated partial thromboplastin time; A10; the amplitude after ten minut
Disconnectivity of the cortical ocular motor control network in autism spectrum disorders
Keywords: ثابت; ASD; Autism spectrum disorder; NT; Neurotypical; AS; Antisaccades; PS; Prosaccades; FIX; Fixation; FEF; Frontal eye field; FEFsR/L; Right and left superior FEF, respectively; FEFiR/L; Right and left inferior FEF, respectively; dAAC; Dorsal anterior cingul
Laboratory identification of factor inhibitors: an update
Keywords: ثابت; APTT; Bethesda assay; Factor inhibitors; lupus inhibitor; mixing tests; replacement therapy; APTT; activated partial thromboplastin time; aVWS; acquired von Willebrand syndrome; DIC; disseminated intravascular coagulation; dRVVT; dilute Russell's viper
Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven®) therapy in haemophilia a patients
Keywords: ثابت; TEG; Thromboelastography; rFVIIa; recombinant Factor VIIa; FVIII; Factor VIII; FIX; Factor IX; FX; Factor X; tPA; tissue plaminogen activator; TF; tissue factor; R-time; Reaction time; MTG; maximum thrombus generation; MA; maximum amplitude; pd-aPCC; acti
L’hémophilie aujourd’hui: hemophilia today
Keywords: ثابت; coagulation; hémarthrose; hématome; hémophilie; hémorragie; FVIII; FIX; prophylaxiecoagulation; hemarthrosis; hematoma; hemophilia; hemorrhage; FVIII; FIX; prophylaxis
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice
Keywords: ثابت; FIX; Factor IX; IV; intravenous; hFIX; human FIX; RV; retroviral vector; MPS I; mucopolysaccharidosis I; CTL; cytotoxic T lymphocyte; cIDUA; canine α-l-iduronidase; WPRE; woodchuck hepatitis virus post-transcriptional regulatory element; IU; internationa
Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study
Keywords: ثابت; TF; tissue factor; FVII; factor VII; FVIIa; factor VIIa; FFR-FVIIa; FVIIa blocked in the active site with phenylalanyl-phenylalanyl-arginyl-chloromethyl ketone; FX; factor X; FIX; factor IX; PCR; polymerase chain reaction; EDTA; ethylenediaminetetraacetic
Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature
Keywords: ثابت; APC; activated protein C; aPTT; activated partial thromboplastin time; AT; antithrombin; BMI; body mass index; CEE; conjugated equine estrogen; DVT; deep vein thrombosis; HERS; Heart and Estrogen/Progestin Replacement Study; E2; estradiol; ET; estrogen th